Catheter Precision (VTAK) Long-Term Deferred Tax (2022 - 2023)
Catheter Precision (VTAK) reported Long-Term Deferred Tax of $26.8 million for Q4 2023, up 207.88% year-over-year from $8.7 million in Q4 2022, and up 207.88% on a QoQ basis from $8.7 million in Q4 2022.
Catheter Precision (VTAK) has 2 years of Long-Term Deferred Tax data on file, last reported at $26.8 million in Q4 2023.
- Quarterly Long-Term Deferred Tax rose 207.88% year-over-year to $26.8 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $26.8 million (up 207.88% YoY) and the FY2023 annual result came in at $26.8 million, up 207.88% from the prior year.
- Long-Term Deferred Tax grew to $26.8 million in Q4 2023 per VTAK's latest filing, from $8.7 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $26.8 million in Q4 2023 and bottomed at $8.7 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Catheter Precision | 2.01 Mn | 1.20 Mn | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 26.77 Mn |
| Dec 31, 2022 | 8.69 Mn |